Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Hold
5,030
0.26% 88
2026
Q1
$278K Hold
5,030
0.28% 90
2025
Q4
$247K Buy
5,030
+300
+6% +$14K 0.25% 89
2025
Q3
$204K Sell
4,730
-980
-17% -$38.3K 0.2% 95
2025
Q2
$219K Buy
5,710
+665
+13% +$25.4K 0.15% 112
2025
Q1
$195K Hold
5,045
0.13% 109
2024
Q4
$171K Sell
5,045
-4,525
-47% -$163K 0.12% 108
2024
Q3
$391K Sell
9,570
-65
-0.7% -$2.66K 0.26% 84
2024
Q2
$371K Sell
9,635
-265
-3% -$11.1K 0.29% 73
2024
Q1
$424K Sell
9,900
-70
-0.7% -$2.89K 0.33% 71
2023
Q4
$369K Sell
9,970
-1,920
-16% -$68.9K 0.3% 76
2023
Q3
$431K Buy
+11,890
New +$422K 0.37% 70

Other funds holding GSK

Peoples Bank (Kansas)'s GSK Position: Q2 2026 in Review

Peoples Bank (Kansas) held its GSK (GSK) position steady in Q2 2026 at 5,030 shares worth $264K. The position accounts for 0.26% of the portfolio, ranked #88.

Peoples Bank (Kansas) first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $431K in Q3 2023. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Peoples Bank (Kansas) held 5,030 shares of GSK worth $264K as of Q2 2026.
  • Peoples Bank (Kansas) left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.26% of Peoples Bank (Kansas)'s portfolio in Q2 2026, its #88 holding.
  • Peoples Bank (Kansas) first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
  • Peoples Bank (Kansas)'s GSK position peaked at $431K in Q3 2023.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Peoples Bank (Kansas)'s 13F filing for Q2 2026, filed 10 Jul 2026.